checkAd

     134  0 Kommentare Jazz Pharmaceuticals Prices $1.5 Billion Senior Secured Notes Offering - Seite 3

    Media Contact:
    Jacqueline Kirby, Vice President, Corporate Affairs & Government Relations
    Ireland +353 1 697 2141     U.S. +1 215 867 4910

    Investor Contact:
    Andrea N. Flynn, Ph.D., Vice President, Head, Investor Relations
    Ireland +353 1 634 7887     U.S. +1 650 496 2717

    Lesen Sie auch

    Logo - https://mma.prnewswire.com/media/272253/Jazz_Pharmaceuticals_Logo.jpg


    PR Newswire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von PR Newswire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Jazz Pharmaceuticals Prices $1.5 Billion Senior Secured Notes Offering - Seite 3 DUBLIN, April 22, 2021 /PRNewswire/ - Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (the "Company" or "Jazz") today announced the pricing of the previously announced offering (the "Offering") of $1.5 billion in an aggregate principal amount of 4.375% …